290 likes | 882 Views
Disorders of Plasma Clotting Factors. Kaur, 2006. Fibrinogen. Prothrombin –Factor 2. Clotting Factors Defects. Decreased Synthesis Production of abnormal molecules Loss of consumption of Coagulation factors Inactivation of factors by inhitors or antibodies.
E N D
Disorders of Plasma Clotting Factors Kaur, 2006
Clotting Factors Defects • Decreased Synthesis • Production of abnormal molecules • Loss of consumption of Coagulation factors • Inactivation of factors by inhitors or antibodies
Transmission of Clotting Factors Disorders Inherited • Sex linked Acquired • Vitamin K deficiency • Liver disease • Hemorrhage • DIC
FACTOR DEFICIENCIES Table 25-1, p496
Von Willebrand’s Disease • Autosomal • Consistently prolonged bleeding time • Mucocutaneous bleeding
Production • Megakaryocytes and endothelial cells • Found in plasma • Stored in plasma granules and endothelial cells • Combines with VIII as VIII:vW • Allows VIII:C to concentrate at site of injury
Correction • Normal plasma
Signs and Symptoms • Mucocutaneous bleeding • Epistaxis • Ecchymosis • Easy bruising • GI bleeding • Menorrhagia • hemorrhage
Function • Carrier protein for VIII:C • Inability of the platelet to adhere to the subendothelial surface
LABORATORY ASSAYS • PT – Normal • APTT – Prolonged -corrects with pooled plasma • Platelets count – normal • Bleeding time – abnormal • Factor VIII:C activity • vWF-Ag concentration • Ristocetin aggregation
TREATMENT • CONCENTRATES OF fviii • CRYOPRECIPITATE • vWF • DESMOPRESSIN
HEMOPHILIA A • Most common hereditary coagulation disorder • Sex linked • Absence of VIII:C (procoagulant factor) • vWF:Ag is normal
INHERITANCE • X-linked (only one chromosome carries the gene for active VIII) • Males inherit from mothers • Daughters carriers • Mutation or silent carriers
Signs and Symptoms • Less than 1% have severe hemorrhage • Hemathrosis
Characteristics of Factor • Acute phase reactant • Minor portion is linked as VIII:C • Major portion is VIII:vW
Laboratory Findings • APTT – prolonged • PT – normal • Bleeding time – normal • Mixing studies with pooled plasma or adsorbed plasma corrects • APTT - Functional activity
TREATMENT • Concentrates of Human Plasma • Purified heat treated lyophilized FVIII (most accepted) • Recombinant-DNA FVIII
FACTOR IX – Christmas Factor/Plasma Thromboplastin Component • Synthesized in the liver • Vitamin k dependent • Intrinsic pathway activated by factor Xia and calcium ions • Activated by Russell viper venom
AGED SERUM Aged serum is prepared by incubating normal serum for 24 hours at 37°C. Lacks • fibrinogen (I), • prothrombin (II), • Factor V, • Factor VIII. Present • Factors VII, • IX, • X, • XI, • XII
ADSORBED PLASMA Platelet-poor plasma that is adsorbed with either barium sulfate or aluminum hydroxide Lacks the coagulation factors • factors II, VII, IX, X (the prothrombin group). Present • Factors V, VIII, XI, XII, and fibrinogen (I)
Hemophilia B (Christmas Disease) • Factor IX deficiency • Sex linked • Acquired • Liver disease • Vitamin K deficiency • Oral anticoagulant therapy
Serious complication • Development of antibodies (differs from Hemophillia A)
Laboratory Findings • PT – Normal • Thrombin Time – Normal • Bleeding Time – Normal • APTT – prolonged • Correction of APTT with pooled normal plasma or aged serum